Market Report Service
Home About Us Industry Report Store Resources Contact us

Solid Tumor Testing Market Growth, Expected to Reach US$ 45.56 Billion by 2030

Solid Tumor Testing Market Growth Analysis by Type (PCR, Genetic Testing), By Application (Prostate, Breast), By End-user, & By Region (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) - Forecast till 2030

5/5
( 18 votes )

Categories: Pharma & Healthcare

Format : Solid Tumor Testing Market Growth, Expected to Reach US$ 45.56 Billion by 2030

Segmentation Fixed Content

Segments Covered in the Solid Tumor Testing Market Report

By Type

  • Genetic Testing (Genetic Test Type (Next generation sequencing (NGS)
  • Real-time PCR (RT-PCR)
  • Fluorescent In-Situ Hybridization (FISH)
  • Fragment Analysis); Conventional Testing

By Application

  • Prostate
  • Breast
  • Colorectal
  • Endometrial
  • Lung
  • Melanoma
  • Brain
  • Thyroid
  • Liver
  • Ovarian

By End User

  • Pharmaceutical and biotechnology companies
  • Hospitals
  • Contract research organizations
  • Academic research institutions

The above information has been provided for the following regions and countries:

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • France
  • Italy
  • Russia

Asia Pacific

  • China
  • India
  • Japan
  • South Korea

Latin America

  • Brazil
  • Mexico

MEA

  • UAE
  • Saudi Arabia
  • South Africa

Select Licence Type


Single User

US$ 2499


Multi User

US$ 3499


Corporate User

US$ 4499

Only one user can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 2499

Multiple users can access the report. It cannot be printed or shared. Delivery in online PDF.

US $ 3499

The entire organization can use the report. It can be printed and shared. Delivery in PDF and Excel. Free update of the report after 1 year.

US $ 4499

Need a Discount? Get in touch with us for special pricing

Connect with our sales team